| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$235,596,155 |
|
|
|
Indirect Value
|
$6,516,227 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$242,112,382 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2016-10-14 |
4 |
A |
$0.81 |
$6,250,000 |
D/D |
7,716,049 |
43,191,009 |
0 |
- |
|
| AZO |
Autozone Inc |
Director |
• • – |
2017-01-01 |
4 |
A |
$789.79 |
$204,998 |
D/D |
260 |
68,628 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-01-03 |
4 |
A |
$5.21 |
$15,625 |
D/D |
2,999 |
4,322,099 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-04-03 |
4 |
A |
$4.90 |
$15,625 |
D/D |
3,189 |
2,075,287 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,130,582 |
3,981,562 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-10-02 |
4 |
A |
$7.94 |
$15,625 |
D/D |
1,968 |
3,983,530 |
0 |
- |
|
| AZO |
Autozone Inc |
Director |
• • – |
2018-01-01 |
4 |
A |
$711.37 |
$214,997 |
D/D |
302 |
71,930 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-01-02 |
4 |
A |
$11.46 |
$15,625 |
D/D |
1,363 |
1,734,893 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-04-02 |
4 |
A |
$17.47 |
$15,625 |
D/D |
894 |
1,927,773 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-07-02 |
4 |
A |
$15.47 |
$15,625 |
D/D |
1,010 |
1,928,783 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-10-01 |
4 |
A |
$1.50 |
$15,625 |
D/D |
10,417 |
1,939,199 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2019-01-02 |
4 |
A |
$0.86 |
$15,625 |
D/D |
18,169 |
4,207,368 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-02-06 |
4 |
B |
$14.50 |
$406,000 |
I/I |
28,000 |
216,462 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-02-06 |
4 |
B |
$14.50 |
$522,000 |
D/D |
36,000 |
7,943,311 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-04 |
4 |
B |
$12.11 |
$122,182 |
I/I |
10,000 |
10,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-07 |
4 |
B |
$12.01 |
$144,620 |
I/I |
12,000 |
22,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-08 |
4 |
B |
$11.83 |
$142,255 |
I/I |
12,000 |
34,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-09 |
4 |
B |
$11.85 |
$142,905 |
I/I |
12,000 |
46,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-10 |
4 |
B |
$11.51 |
$138,463 |
I/I |
12,000 |
58,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-14 |
4 |
B |
$11.57 |
$163,296 |
I/I |
14,000 |
72,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-03 |
4 |
B |
$9.28 |
$93,391 |
I/I |
10,000 |
8,200 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-04 |
4 |
B |
$8.96 |
$135,222 |
I/I |
15,000 |
97,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-05 |
4 |
B |
$8.94 |
$44,704 |
I/I |
5,000 |
102,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-06 |
4 |
B |
$8.76 |
$88,739 |
I/I |
10,000 |
112,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-09 |
4 |
B |
$8.86 |
$89,896 |
I/I |
10,000 |
122,000 |
2.25 |
- |
|
178 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
